Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Lord

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Transplantation|January 1, 1988
Synergy between subtherapeutic doses of cyclosporine and immunologic enhancement in rat recipients of cardiac allograftsW M Padberg, R H Lord, R Di Stefano, et al.
Transplantation|August 1, 1988
Synergy between subtherapeutic doses of cyclosporine and immunobiological manipulations in rat heart graft recipientsN L Tilney, W M Padberg, R H Lord, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1992
EBV-genome positive monoclonal B cell cerebral lymphoma in a renal allograft recipient following OKT3 therapyJ T Kwan, F E Cotter, L E Pollock, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
A double-blind, randomized, placebo-controlled study of nifedipine on early renal allograft functionM E Wilkie, J C Beer, S J Evans, et al.
Transplantation Proceedings|February 1, 1987
Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the ratR H Lord, W W Hancock, A J Colby, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1987
Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporinW W Hancock, R H Lord, A J Colby, et al.
Transplantation Proceedings|October 1, 1987
Synergy between cyclosporine and other immunosuppressive regimens in experimental organ transplantationW M Padberg, R Di Stefano, R H Lord, et al.
European Journal of Immunology|March 1, 1987
Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allograftsJ W Kupiec-Weglinski, W Padberg, L C Uhteg, et al.
Transplantation Proceedings|February 1, 1987
Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ graftsJ W Kupiec-Weglinski, W Padberg, L C Uhteg, et al.
Transplantation Proceedings|April 1, 1988
Immunohistologic profile of cells infiltrating acutely rejecting and long-surviving rat cardiac allograftsR H Lord, W M Padberg, R Di Stefano, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Transplantation|January 1, 1988
Synergy between subtherapeutic doses of cyclosporine and immunologic enhancement in rat recipients of cardiac allograftsW M Padberg, R H Lord, R Di Stefano, et al.
Transplantation|August 1, 1988
Synergy between subtherapeutic doses of cyclosporine and immunobiological manipulations in rat heart graft recipientsN L Tilney, W M Padberg, R H Lord, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1992
EBV-genome positive monoclonal B cell cerebral lymphoma in a renal allograft recipient following OKT3 therapyJ T Kwan, F E Cotter, L E Pollock, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
A double-blind, randomized, placebo-controlled study of nifedipine on early renal allograft functionM E Wilkie, J C Beer, S J Evans, et al.
Transplantation Proceedings|February 1, 1987
Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the ratR H Lord, W W Hancock, A J Colby, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1987
Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporinW W Hancock, R H Lord, A J Colby, et al.
Transplantation Proceedings|October 1, 1987
Synergy between cyclosporine and other immunosuppressive regimens in experimental organ transplantationW M Padberg, R Di Stefano, R H Lord, et al.
European Journal of Immunology|March 1, 1987
Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allograftsJ W Kupiec-Weglinski, W Padberg, L C Uhteg, et al.
Transplantation Proceedings|February 1, 1987
Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ graftsJ W Kupiec-Weglinski, W Padberg, L C Uhteg, et al.
Transplantation Proceedings|April 1, 1988
Immunohistologic profile of cells infiltrating acutely rejecting and long-surviving rat cardiac allograftsR H Lord, W M Padberg, R Di Stefano, et al.
Pageof 4